These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A defensive strategy. Lok C Nature; 2005 Oct; 437(7063):1392-3. PubMed ID: 16283702 [No Abstract] [Full Text] [Related]
3. Bioterrorism--biotechnology to the rescue? Niiler E Nat Biotechnol; 2002 Jan; 20(1):21-5. PubMed ID: 11753354 [No Abstract] [Full Text] [Related]
4. US expands anti-bioterrorist measures. Fox JL Nat Biotechnol; 2001 Nov; 19(11):998-1000. PubMed ID: 11689831 [No Abstract] [Full Text] [Related]
5. Bioterrorism: what level is the threat and are vaccines the answer? Smith LA Expert Rev Vaccines; 2004 Oct; 3(5):493-5. PubMed ID: 15485326 [No Abstract] [Full Text] [Related]
6. US rejiggers Bioshield bill. Herrera S Nat Biotechnol; 2004 Jul; 22(7):792. PubMed ID: 15229526 [No Abstract] [Full Text] [Related]
7. US biodefense contracts continue to lure biotechs. Shaffer C Nat Biotechnol; 2010 Mar; 28(3):187-8. PubMed ID: 20212465 [No Abstract] [Full Text] [Related]
13. Lessons learned from the CDC's post-exposure prophylaxis program following the anthrax attacks of 2001. Bresnitz EA Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):389-91. PubMed ID: 15924332 [No Abstract] [Full Text] [Related]
14. Old legacies and new paradigms: confusing "research" and "treatment" and its consequences in responding to emergent health threats. Javitt GH J Health Care Law Policy; 2005; 8(1):38-70. PubMed ID: 16538801 [No Abstract] [Full Text] [Related]
15. Impending breakthroughs could turn more small biotech firms into major companies. Wagner M Mod Healthc; 1988 Mar; 18(10):41. PubMed ID: 10286307 [No Abstract] [Full Text] [Related]
16. Biotechnology to fight bioterrorism. While the fight against terrorism is helping to revitalize the biotech market, academic scientists are starting to worry about limitations on research. Brower V EMBO Rep; 2003 Mar; 4(3):227-9. PubMed ID: 12634833 [TBL] [Abstract][Full Text] [Related]